Early Mobilization of Spiral Metacarpal Fractures Compared With Operative Treatment
1 other identifier
interventional
42
1 country
2
Brief Summary
Spiral metacarpal fractures (metacarpal II-V) can be treated conservatively or with operation. With minimal displacement this fracture is usually treated with immobilisation or early mobilisation. With appreciable displacement especially any malrotation the patient usually is treated with an operation. This usually includes an open reduction of the fracture and fixation with plates and screws or just screws. Even if this is an standard procedure both mild and severe complications have been reported. New studies have shown that even displaced fractures can be treated with early mobilization. In those cases the fractures may heal with some shortening but very good function. An advantage of early mobilization is that the patient avoids the risk of an operation and the costs for the treatment are decreased markedly. The study is designed to answer the question if early mobilization is not inferior to operative treatment but with lower costs and without any operation related risks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2017
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2017
CompletedFirst Posted
Study publicly available on registry
March 1, 2017
CompletedStudy Start
First participant enrolled
March 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 28, 2021
CompletedJuly 16, 2021
July 1, 2021
4.2 years
February 21, 2017
July 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Grip-strength measured by the JAMAR dynamometer
Power of the treated hand measured by the JAMAR dynamometer compared with the none-operated hand
1 year
Secondary Outcomes (5)
Handfunction rated by the DASH-score
1 year
Range of motion in the treated hand/fingerray
1 year
Appearance and severity of complications
1 year
Time until the patient can return to work, driving and sport
1 year
The total costs of each treatment
1 year
Study Arms (2)
conservative group
OTHERTreatment with early mobilisation
operative group
OTHERTreatment with operation
Interventions
Conservative treatment with early mobilisation The patient is instructed to do a fist and is not allowed to leave the clinic before. Active mobilisation under control (doctor or physiotherapist) is performed until healing of the fracture is documented.
Operation of the fracture. Usually open reduction and internal fixation with plates and screws or just screws within 2 weeks of injury. Immobilisation in a cast for two weeks followed by physiotherapy.
Eligibility Criteria
You may qualify if:
- single spiral fractures of metacarpal bone II-V
- fracture line at least twice the length of the diameter of the bone at the level of the fracture
- at least 1-2mm displacement of the fracture and/or malrotation
- normal hand function before the injury
- fracture less than 10 days old
You may not qualify if:
- multiple metacarpal fractures
- open fractures
- incompliance or dementia
- fracture line not twice the length of the diameter of the bone at the level of the fracture
- abnormal hand function before the injury
- fracture more than 10 days old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Falu lasarett, Department of Orthopedics
Falun, Dalarna County, 79182, Sweden
Uppsala University Hospital, Dept. of Handsurgery
Uppsala, Uppsala County, 75185, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Nils Hailer, Professor
Department of Orthopedics, Uppsala University Hospital
- PRINCIPAL INVESTIGATOR
Daniel Muder, MD, Dr. med.
Department of Orthopedics, Falu lasarett
- PRINCIPAL INVESTIGATOR
Grey Giddins, M.B.B.Ch. F.R.C.S. (Orth)
Royal United Hospitals Bath NHS Foundation Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2017
First Posted
March 1, 2017
Study Start
March 1, 2017
Primary Completion
May 28, 2021
Study Completion
May 28, 2021
Last Updated
July 16, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share